Brian Concannon, President & CEO, Director at Haemonetics, holds 9.34K shares in Conmed (Ticker: CNMD), holds 147.04K shares in Haemonetics (Ticker: HAE). Most recently, Brian Concannon Sold ― shares of Conmed on Jun 08, 2023 for an estimated value of 104.76K.